Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter.
Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter.
复制标题
DOI:
10.3389/fnmol.2017.00040
复制
发表时间:
2017
影响因子:
4.8
通讯作者:
Benn CL
中科院分区:
文献类型:
--
作者:
Choudhary P;Armstrong EJ;Jorgensen CC;Piotrowski M;Barthmes M;Torella R;Johnston SE;Maruyama Y;Janiszewski JS;Storer RI;Skerratt SE;Benn CL
Cholinergic hypofunction is associated with decreased attention and cognitive deficits in the central nervous system in addition to compromised motor function. Consequently, stimulation of cholinergic neurotransmission is a rational therapeutic approach for the potential treatment of a variety of neurological conditions. High affinity choline uptake (HACU) into acetylcholine (ACh)-synthesizing neurons is critically mediated by the sodium- and pH-dependent high-affinity choline transporter (CHT, encoded by the SLC5A7 gene). This transporter is comparatively well-characterized but otherwise unexplored as a potential drug target. We therefore sought to identify small molecules that would enable testing of the hypothesis that positive modulation of CHT mediated transport would enhance activity-dependent cholinergic signaling. We utilized existing and novel screening techniques for their ability to reveal both positive and negative modulation of CHT using literature tools. A screening campaign was initiated with a bespoke compound library comprising both the Pfizer Chemogenomic Library (CGL) of 2,753 molecules designed specifically to help enable the elucidation of new mechanisms in phenotypic screens and 887 compounds from a virtual screening campaign to select molecules with field-based similarities to reported negative and positive allosteric modulators. We identified a number of previously unknown active and structurally distinct molecules that could be used as tools to further explore CHT biology or as a starting point for further medicinal chemistry.